News Focus
News Focus
Replies to #96259 on Biotech Values
icon url

genisi

08/09/11 4:20 PM

#124872 RE: DewDiligence #96259

Daclizumab's phase IIb SELECT trial top-line results:

http://www.biogenidec.com/press_release_details.aspx?ID=5981&ReqId=1594585